Clinical Trial Update: Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing R-GemOx to R-miniCHOP as first-line therapy for elderly patients with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-GemOx (rituximab, gemcitabine, oxaliplatin)
• R-miniCHOP (undefined)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Diffuse Large B Cell Lymphoma | Phase 3 | Status: UNKNOWN